Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-17

Clinical Trial Update: Splanchnic X: Splanchnic Nerve Block in Heart Failure With Reduced Ejection Fraction [NA]

View source ↗

Summary

A clinical trial evaluating splanchnic nerve block for heart failure with reduced ejection fraction is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Duke University | Conditions: Heart Failure | NA | Status: RECRUITING